Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06834035

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:08.068671+00:00

Published At

2026-03-25T00:00:00+00:00

Record Updated At

2026-03-25

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Epidermolysis Bullosa", "Epidermolysis Bullosa Acquisita", "Dystrophic Epidermolysis Bullosa", "Recessive Dystrophic Epidermolysis Bullosa"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-03-25"

protocolSection.identificationModule.nctId

"NCT06834035"

protocolSection.identificationModule.officialTitle

"Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE1", "PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Epidermolysis Bullosa (protocolSection.conditionsModule.conditions)
• Epidermolysis Bullosa Acquisita (protocolSection.conditionsModule.conditions)
• Dystrophic Epidermolysis Bullosa (protocolSection.conditionsModule.conditions)
• Recessive Dystrophic Epidermolysis Bullosa (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.